Why Is Medical Coating Specialist Surmodics Trading Higher On Wednesday?
Why Is Medical Coating Specialist Surmodics Trading Higher On Wednesday?
Private equity firm GTCR agreed to acquire medical device coating company Surmodics Inc (NASDAQ:SRDX) for approximately $627 million, or $43 per share.
私募股權公司GTCR同意收購醫療器械塗層公司Surmodics Inc (納斯達克：surmodics)約6270萬美元，即每股43美元。
The per-share acquisition price represents a 41.1% premium to Surmodics' 30-trading day volume-weighted average closing price through May 28.
每股收購價較Surmodics 5月28日30個交易日的成交量加權平均收盤價溢價41.1%。
Surmodics' board unanimously approved the cash deal. It also recommended that stockholders vote in favor of the transaction.
Surmodics董事會一致同意這筆現金交易，並建議股東投票支持此交易。
"We are pleased to announce this transaction, which enables Surmodics shareholders to realize immediate value creation with a substantial premium, reflecting the significant progress and important achievements made by our employees," said Surmodics CEO Gary Maharaj said.
"我們很高興宣佈這筆交易，Surmodics股東可以實現即時增值，享有一定溢價，這反映了我們的員工取得的重大進展和重大成就，" Surmodics首席執行官Gary Maharaj說。
GTCR managing director Sean Cunningham praised Surmodics as "well-positioned for attractive, long-term growth and value creation."
GTCR管理董事Sean Cunningham稱讚Surmodics "處於有吸引力的、長期增長和價值創造的良好位置。"
The transaction is expected to close in the second half of 2024.
交易預計將在2024年下半年完成。
Upon completion of the transaction, Surmodics will be a privately held company, and its common stock will no longer be listed on The Nasdaq Stock Exchange.
交易完成後，Surmodics將成爲一傢俬有公司，其普通股不再上市納斯達克交易所。
Price Action: SRDX shares are up 20.3% at $42.24 at last check Wednesday.
價格走勢：截至上週三，SRDX股價上漲20.3%，報42.24美元。
Now Read: Coinbase Stock Is Trading Lower, What's Going On?
現在閱讀：Coinbase股票價格下跌，發生了什麼？